Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |